![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 49, 51131-51140, December 3, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



**
From the
Departments of Biological Sciences, ¶Chemistry, and ||Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260
The molecular chaperone and cytoprotective activities of the Hsp70 and Hsp40 chaperones represent therapeutic targets for human diseases such as cancer and those that arise from defects in protein folding; however, very few Hsp70 and no Hsp40 modulators have been described. Using an assay for ATP hydrolysis, we identified and screened small molecules with structural similarity to 15-deoxyspergualin and NSC 630668-R/1 for their effects on endogenous and Hsp40-stimulated Hsp70 ATPase activity. Several of these compounds modulated Hsp70 ATPase activity, consistent with the action of NSC 630668-R/1 observed previously (Fewell, S. W., Day, B. W., and Brodsky, J. L. (2001) J. Biol. Chem. 276, 910914). In contrast, three compounds inhibited the ability of Hsp40 to stimulate Hsp70 ATPase activity but did not affect the endogenous activity of Hsp70. Two of these agents also compromised the Hsp70/Hsp40-mediated post-translational translocation of a secreted pre-protein in vitro. Together, these data indicate the potential for continued screening of small molecule Hsp70 effectors and that specific modulators of Hsp70-Hsp40 interaction can be obtained, potentially for future therapeutic use.
Received for publication, April 30, 2004 , and in revised form, September 8, 2004.
* This work was supported in part by National Institutes of Health Grants CA78039 (to P. W. and B. W. D.), CA099024 (to J. L. B.), and GM067082 (to the University of Pittsburgh Center for Chemical Methodologies and Library Development). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a National Institutes of Health National Research Service Award.
** To whom correspondence should be addressed: Dept. of Biological Sciences, 274 Crawford Hall, University of Pittsburgh, Pittsburgh, PA 15260. Tel.: 412-624-4831; Fax: 412-624-4759; E-mail: jbrodsky{at}pitt.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Morishima, A. M. Wang, Z. Yu, W. B. Pratt, Y. Osawa, and A. P. Lieberman CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins Hum. Mol. Genet., December 15, 2008; 17(24): 3942 - 3952. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rabu, P. Wipf, J. L. Brodsky, and S. High A Precursor-specific Role for Hsp40/Hsc70 during Tail-anchored Protein Integration at the Endoplasmic Reticulum J. Biol. Chem., October 10, 2008; 283(41): 27504 - 27513. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Evans, S. Wisen, and J. E. Gestwicki Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid beta-(1-42) Aggregation in Vitro J. Biol. Chem., November 3, 2006; 281(44): 33182 - 33191. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, B. Z. Schmidt, F. Sun, S. B. Condliffe, M. B. Butterworth, R. T. Youker, J. L. Brodsky, M. Aridor, and R. A. Frizzell Cysteine String Protein Monitors Late Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis J. Biol. Chem., April 21, 2006; 281(16): 11312 - 11321. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |